Medicus Pharma Ltd. (CVE:MDC – Free Report) – Equities research analysts at Brookline Capital Management raised their FY2025 earnings per share estimates for shares of Medicus Pharma in a research report issued on Tuesday, April 8th. Brookline Capital Management analyst K. Raja now anticipates that the company will earn ($1.25) per share for the year, up from their previous estimate of ($2.20). Brookline Capital Management also issued estimates for Medicus Pharma’s FY2026 earnings at ($1.22) EPS, FY2027 earnings at ($0.92) EPS and FY2028 earnings at $0.62 EPS.
Medicus Pharma Stock Performance
Further Reading
- Five stocks we like better than Medicus Pharma
- What Are the U.K. Market Holidays? How to Invest and Trade
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- P/E Ratio Calculation: How to Assess Stocks
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- How to invest in marijuana stocks in 7 steps
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
